{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:33:14Z","timestamp":1790667194987,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009991","name":"Department of Finance of Jilin Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009991","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202101ZYTS082"],"award-info":[{"award-number":["YDZJ202101ZYTS082"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.biopha.2024.117138","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T09:54:18Z","timestamp":1721210058000},"page":"117138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Intermittent pulses of methylprednisolone with low-dose prednisone attenuate lupus symptoms in B6.MRL-Faslpr\/J mice with fewer glucocorticoid side effects"],"prefix":"10.1016","volume":"177","author":[{"given":"Lu","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishuang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2024.117138_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","article-title":"Immunological pathogenesis and treatment of systemic lupus erythematosus","volume":"16","author":"Pan","year":"2020","journal-title":"World J. Pedia"},{"key":"10.1016\/j.biopha.2024.117138_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2023.101895","article-title":"Management of systemic lupus erythematosus: a new scenario","author":"Moysidou","year":"2023","journal-title":"Best. Pr. Res Clin. Rheuma"},{"issue":"11","key":"10.1016\/j.biopha.2024.117138_bib3","doi-asserted-by":"crossref","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann. Intern Med"},{"issue":"9","key":"10.1016\/j.biopha.2024.117138_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2019-215716","article-title":"2019 update of the EULAR recommendations for the management of SLE: don't forget chloroquine","volume":"79","author":"Figueroa-Parra","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2024.117138_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","article-title":"Update \u03bfn the diagnosis and management of systemic lupus erythematosus","volume":"80","author":"Fanouriakis","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2024.117138_bib6","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2024.117138_bib7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.21664","article-title":"American college of Rheumatology guidelines for screening, treatment, and management of lupus nephritis","volume":"64","author":"Hahn","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.biopha.2024.117138_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/rheumatology\/kex286","article-title":"The british society for rheumatology guideline for the management of systemic lupus erythematosus in adults","volume":"57","author":"Gordon","year":"2018","journal-title":"Rheumatol. (Oxf. )"},{"issue":"Suppl5","key":"10.1016\/j.biopha.2024.117138_bib9","doi-asserted-by":"crossref","first-page":"v69","DOI":"10.1093\/rheumatology\/keaa403","article-title":"Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs","volume":"59","author":"Ruiz-Irastorza","year":"2020","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.biopha.2024.117138_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12364","article-title":"Unraveling the functions of the membrane-bound glucocorticoid receptors: first clues on origin and functional activity","volume":"1318","author":"Strehl","year":"2014","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.117138_bib11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/0378-6323.204202","article-title":"Effect of intravenous pulse dexamethasone versus daily oral prednisolone on bone mineral density in dermatology patients: Is it a site-specific response?","volume":"84","author":"Handa","year":"2018","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"issue":"11","key":"10.1016\/j.biopha.2024.117138_bib12","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/resp.13365","article-title":"Multidimensional improvement in connective tissue disease-associated interstitial lung disease: two courses of pulse dose methylprednisolone followed by low-dose prednisone and tacrolimus","volume":"23","author":"Yamano","year":"2018","journal-title":"Respirology"},{"issue":"8","key":"10.1016\/j.biopha.2024.117138_bib13","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/rheumatology\/keu148","article-title":"Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus","volume":"53","author":"Ruiz-Arruza","year":"2014","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.biopha.2024.117138_bib14","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.autrev.2017.05.017","article-title":"Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: an observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts","volume":"16","author":"Ruiz-Irastorza","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2024.117138_bib15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/BOR.0000000000000527","article-title":"Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions","volume":"30","author":"Ugarte","year":"2018","journal-title":"Curr. Opin. Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2024.117138_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","article-title":"Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids","volume":"44","author":"Czock","year":"2005","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.biopha.2024.117138_bib17","doi-asserted-by":"crossref","first-page":"1128754","DOI":"10.3389\/fimmu.2023.1128754","article-title":"Childhood-onset systemic lupus erythematosus: characteristics and the prospect of glucocorticoid pulse therapy","volume":"14","author":"Pan","year":"2023","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117138_bib18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/ilar\/ilu045","article-title":"Randomized block experimental designs can increase the power and reproducibility of laboratory animal experiments","volume":"55","author":"Festing","year":"2014","journal-title":"Ilar J."},{"issue":"12","key":"10.1016\/j.biopha.2024.117138_bib19","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/rheumatology\/kes227","article-title":"Attenuation of nephritis in lupus-prone mice by thalidomide","volume":"51","author":"Lee","year":"2012","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.biopha.2024.117138_bib20","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s12882-019-1599-0","article-title":"The new complement inhibitor CRIg\/FH ameliorates lupus nephritis in lupus-prone MRL\/lpr mice","volume":"20","author":"Shi","year":"2019","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.biopha.2024.117138_bib21","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.2147\/DDDT.S110125","article-title":"Effects of salvianolate on bone metabolism in glucocorticoid-treated lupus-prone B6.MRL-Fas (lpr) \/J mice","volume":"10","author":"Liu","year":"2016","journal-title":"Drug Des. Devel Ther."},{"issue":"10","key":"10.1016\/j.biopha.2024.117138_bib22","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1177\/0961203320930099","article-title":"Seventy years after Hench's Nobel prize: revisiting the use of glucocorticoids in systemic lupus erythematosus","volume":"29","author":"Ruiz-Irastorza","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.biopha.2024.117138_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108650","article-title":"Effect of caffeine on ovariectomy-induced osteoporosis in rats","volume":"112","author":"Xu","year":"2019","journal-title":"Biomed. Pharm."},{"issue":"11","key":"10.1016\/j.biopha.2024.117138_bib24","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1172\/JCI63377","article-title":"Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism","volume":"122","author":"Brennan-Speranza","year":"2012","journal-title":"J. Clin. Invest"},{"issue":"5","key":"10.1016\/j.biopha.2024.117138_bib25","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1021\/acs.molpharmaceut.7b01146","article-title":"Double-edged effect of hydroxychloroquine on human umbilical cord-derived mesenchymal stem cells treating lupus nephritis in MRL\/lpr mice","volume":"15","author":"Mai","year":"2018","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2024.117138_bib26","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.1021\/acsnano.8b01249","article-title":"Micelle-forming dexamethasone prodrug attenuates nephritis in lupus-prone mice without apparent glucocorticoid side effects","volume":"12","author":"Jia","year":"2018","journal-title":"ACS Nano"},{"issue":"18","key":"10.1016\/j.biopha.2024.117138_bib27","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.7150\/thno.17949","article-title":"Autophagy maintains the function of bone marrow mesenchymal stem cells to prevent estrogen deficiency-induced osteoporosis","volume":"7","author":"Qi","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2024.117138_bib28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.biopha.2018.03.125","article-title":"Tea polysaccharide inhibits RANKL-induced osteoclastogenesis in RAW264.7 cells and ameliorates ovariectomy-induced osteoporosis in rats","volume":"102","author":"Xu","year":"2018","journal-title":"Biomed. Pharm."},{"issue":"9","key":"10.1016\/j.biopha.2024.117138_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092554","article-title":"Protective Effects of 2,3,5,4\u2032-Tetrahydroxystilbene-2-O-\u03b2-d-glucoside on Ovariectomy Induced Osteoporosis Mouse Model","volume":"19","author":"Kim","year":"2018","journal-title":"Int J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2024.117138_bib30","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/s41423-020-0472-1","article-title":"Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus","volume":"18","author":"Jin","year":"2021","journal-title":"Cell Mol. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2024.117138_bib31","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/eji.201847547","article-title":"Regulatory IFN-\u03b3-producing killer dendritic cells are enhanced in B6.MLR-Fas(lpr) \/J lupus-prone mice.","volume":"48","author":"Rodr\u00edguez-Alba","year":"2018","journal-title":"Eur. J. Immunol."},{"issue":"1-2","key":"10.1016\/j.biopha.2024.117138_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2007.05.015","article-title":"Glucocorticoids, metabolism and metabolic diseases","volume":"275","author":"Vegiopoulos","year":"2007","journal-title":"Mol. Cell Endocrinol."},{"issue":"11","key":"10.1016\/j.biopha.2024.117138_bib33","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/jbmr.2270","article-title":"Loss of Gs\u03b1 early in the osteoblast lineage favors adipogenic differentiation of mesenchymal progenitors and committed osteoblast precursors","volume":"29","author":"Sinha","year":"2014","journal-title":"J. Bone Min. Res"},{"issue":"6937","key":"10.1016\/j.biopha.2024.117138_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biopha.2024.117138_bib35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/art.40697","article-title":"Long-term clinical outcomes in a cohort of adults with childhood-onset systemic lupus erythematosus","volume":"71","author":"Groot","year":"2019","journal-title":"Arthritis Rheuma"},{"issue":"10188","key":"10.1016\/j.biopha.2024.117138_bib36","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","article-title":"Management strategies and future directions for systemic lupus erythematosus in adults","volume":"393","author":"Durcan","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.biopha.2024.117138_bib37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12016-020-08798-2","article-title":"Type I interferons in the pathogenesis and treatment of autoimmune diseases","volume":"59","author":"Jiang","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.biopha.2024.117138_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coi.2020.10.014","article-title":"Type I interferon in the pathogenesis of systemic lupus erythematosus","volume":"67","author":"Postal","year":"2020","journal-title":"Curr. Opin. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.117138_bib39","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1016\/S2665-9913(21)00006-0","article-title":"Glucocorticoid gene signatures in systemic lupus erythematosus and the effects of type I interferon: a cross-sectional and in-vitro study","volume":"3","author":"Northcott","year":"2021","journal-title":"Lancet Rheumatol."},{"issue":"7300","key":"10.1016\/j.biopha.2024.117138_bib40","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nature09102","article-title":"TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus","volume":"465","author":"Guiducci","year":"2010","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.biopha.2024.117138_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102359","article-title":"Prolonged remission in SLE is possible by using reduced doses of prednisone: an observational study from the Lupus-Cruces and Lupus-Bordeaux inception cohorts","volume":"18","author":"Ruiz-Irastorza","year":"2019","journal-title":"Autoimmun. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2024.117138_bib42","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0952-7915(94)90013-2","article-title":"Apoptosis, Fas and systemic autoimmunity: the MRL-lpr\/lpr model","volume":"6","author":"Singer","year":"1994","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biopha.2024.117138_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109079","article-title":"Methylprednisolone pulse therapy promotes the differentiation of regulatory T cells by inducing the apoptosis of CD4(+) T cells in patients with systemic lupus erythematosus","volume":"241","author":"Sun","year":"2022","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117138_bib44","first-page":"1083","article-title":"Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: a 12-month randomized prospective controlled study","volume":"31","author":"Frediani","year":"2004","journal-title":"J. Rheuma"},{"issue":"6","key":"10.1016\/j.biopha.2024.117138_bib45","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1210\/en.2018-00147","article-title":"Glucocorticoid-induced metabolic disturbances are exacerbated in obese male mice","volume":"159","author":"Harvey","year":"2018","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.biopha.2024.117138_bib46","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00125-019-4887-0","article-title":"Androgens sensitise mice to glucocorticoid-induced insulin resistance and fat accumulation","volume":"62","author":"Gasparini","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2024.117138_bib47","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jsbmb.2018.08.010","article-title":"Glucocorticoid-induced insulin resistance is related to macrophage visceral adipose tissue infiltration","volume":"185","author":"Do","year":"2019","journal-title":"J. Steroid Biochem Mol. Biol."},{"issue":"12","key":"10.1016\/j.biopha.2024.117138_bib48","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.2337\/dc06-1499","article-title":"Risk of diabetes associated with prescribed glucocorticoids in a large population","volume":"29","author":"Gulliford","year":"2006","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.biopha.2024.117138_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2362.2008.02067.x","article-title":"Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?","volume":"39","author":"van Raalte","year":"2009","journal-title":"Eur. J. Clin. Invest"},{"issue":"2","key":"10.1016\/j.biopha.2024.117138_bib50","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cell.2010.06.002","article-title":"Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition","volume":"142","author":"Fulzele","year":"2010","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.biopha.2024.117138_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168503","article-title":"Genomic and non-genomic actions of glucocorticoids on adipose tissue lipid metabolism","volume":"22","author":"Mir","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2024.117138_bib52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41584-020-0371-y","article-title":"Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases","volume":"16","author":"Hardy","year":"2020","journal-title":"Nat. Rev. Rheuma"},{"issue":"2","key":"10.1016\/j.biopha.2024.117138_bib53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.semarthrit.2019.03.010","article-title":"Glucocorticoids pharmacology and their application in the treatment of childhood-onset systemic lupus erythematosus","volume":"49","author":"Deng","year":"2019","journal-title":"Semin Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.biopha.2024.117138_bib54","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/cen.12728","article-title":"Glucocorticoid receptor function in health and disease","volume":"83","author":"Caratti","year":"2015","journal-title":"Clin. Endocrinol. (Oxf. )"},{"issue":"8","key":"10.1016\/j.biopha.2024.117138_bib55","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s10067-017-3711-9","article-title":"Glucocorticoid-induced leucine zipper expression is associated with response to treatment and immunoregulation in systemic lupus erythematosus","volume":"36","author":"Mohammadi","year":"2017","journal-title":"Clin. Rheuma"},{"issue":"8","key":"10.1016\/j.biopha.2024.117138_bib56","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1074\/jbc.M704147200","article-title":"Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ)","volume":"283","author":"Zhang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.117138_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102858","article-title":"GILZ regulates type I interferon release and sequesters STAT1","volume":"131","author":"Nataraja","year":"2022","journal-title":"J. Autoimmun."},{"issue":"44","key":"10.1016\/j.biopha.2024.117138_bib58","doi-asserted-by":"crossref","first-page":"22949","DOI":"10.1074\/jbc.M116.733253","article-title":"Induction of Glucocorticoid-induced Leucine Zipper (GILZ) Contributes to anti-inflammatory effects of the natural product curcumin in macrophages","volume":"291","author":"Hoppst\u00e4dter","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.117138_bib59","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3389\/fimmu.2019.01684","article-title":"Could GILZ be the answer to glucocorticoid toxicity in lupus?","volume":"10","author":"Flynn","year":"2019","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2024.117138_bib60","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/rheumatology\/39.4.389","article-title":"Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spine","volume":"39","author":"Jardinet","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.biopha.2024.117138_bib61","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3389\/fimmu.2017.00403","article-title":"Dual Role of Fas\/FasL-mediated signal in peripheral immune tolerance","volume":"8","author":"Yamada","year":"2017","journal-title":"Front. Immunol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224010229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224010229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:06:30Z","timestamp":1782173190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224010229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":61,"alternative-id":["S0753332224010229"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117138","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intermittent pulses of methylprednisolone with low-dose prednisone attenuate lupus symptoms in B6.MRL-Faslpr\/J mice with fewer glucocorticoid side effects","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117138"}}